CellaVision AB Statistics
Total Valuation
CellaVision AB has a market cap or net worth of EUR 378.93 million. The enterprise value is 367.59 million.
Market Cap | 378.93M |
Enterprise Value | 367.59M |
Important Dates
The next estimated earnings date is Thursday, November 6, 2025.
Earnings Date | Nov 6, 2025 |
Ex-Dividend Date | May 7, 2025 |
Share Statistics
Current Share Class | 23.85M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 19.82M |
Valuation Ratios
The trailing PE ratio is 27.99 and the forward PE ratio is 23.12.
PE Ratio | 27.99 |
Forward PE | 23.12 |
PS Ratio | 5.63 |
PB Ratio | 5.14 |
P/TBV Ratio | 13.66 |
P/FCF Ratio | 22.08 |
P/OCF Ratio | 20.51 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.77, with an EV/FCF ratio of 21.42.
EV / Earnings | 27.15 |
EV / Sales | 5.40 |
EV / EBITDA | 17.77 |
EV / EBIT | 20.58 |
EV / FCF | 21.42 |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.04.
Current Ratio | 3.19 |
Quick Ratio | 2.28 |
Debt / Equity | 0.04 |
Debt / EBITDA | 0.13 |
Debt / FCF | 0.16 |
Interest Coverage | 30.75 |
Financial Efficiency
Return on equity (ROE) is 19.35% and return on invested capital (ROIC) is 15.05%.
Return on Equity (ROE) | 19.35% |
Return on Assets (ROA) | 12.30% |
Return on Invested Capital (ROIC) | 15.05% |
Return on Capital Employed (ROCE) | 21.45% |
Revenue Per Employee | 293,840 |
Profits Per Employee | 59,115 |
Employee Count | 219 |
Asset Turnover | 0.75 |
Inventory Turnover | 2.00 |
Taxes
In the past 12 months, CellaVision AB has paid 3.56 million in taxes.
Income Tax | 3.56M |
Effective Tax Rate | 20.81% |
Stock Price Statistics
The stock price has decreased by -37.88% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -37.88% |
50-Day Moving Average | 15.49 |
200-Day Moving Average | 16.53 |
Relative Strength Index (RSI) | 48.15 |
Average Volume (20 Days) | 206 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellaVision AB had revenue of EUR 67.29 million and earned 13.54 million in profits. Earnings per share was 0.57.
Revenue | 67.29M |
Gross Profit | 46.32M |
Operating Income | 17.66M |
Pretax Income | 17.09M |
Net Income | 13.54M |
EBITDA | 19.38M |
EBIT | 17.66M |
Earnings Per Share (EPS) | 0.57 |
Balance Sheet
The company has 13.90 million in cash and 2.70 million in debt, giving a net cash position of 11.20 million.
Cash & Cash Equivalents | 13.90M |
Total Debt | 2.70M |
Net Cash | 11.20M |
Net Cash Per Share | n/a |
Equity (Book Value) | 73.69M |
Book Value Per Share | 3.09 |
Working Capital | 25.00M |
Cash Flow
In the last 12 months, operating cash flow was 18.48 million and capital expenditures -1.32 million, giving a free cash flow of 17.16 million.
Operating Cash Flow | 18.48M |
Capital Expenditures | -1.32M |
Free Cash Flow | 17.16M |
FCF Per Share | n/a |
Margins
Gross margin is 68.83%, with operating and profit margins of 26.24% and 20.12%.
Gross Margin | 68.83% |
Operating Margin | 26.24% |
Pretax Margin | 25.40% |
Profit Margin | 20.12% |
EBITDA Margin | 28.80% |
EBIT Margin | 26.24% |
FCF Margin | 25.50% |
Dividends & Yields
This stock pays an annual dividend of 0.23, which amounts to a dividend yield of 1.48%.
Dividend Per Share | 0.23 |
Dividend Yield | 1.48% |
Dividend Growth (YoY) | 18.98% |
Years of Dividend Growth | n/a |
Payout Ratio | 39.44% |
Buyback Yield | n/a |
Shareholder Yield | 1.48% |
Earnings Yield | 3.57% |
FCF Yield | 4.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 7 |